Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 221 | SRPT Sarepta Therapeutics,, Inc. Common Stock | 21.73 USD | -1.90% | -0.78% | +31.70% | -60.22% | 2.28 B USD | ||
| 222 | ADPT Adaptive Biotechnologies Corporation Common Stock | 14.5300 USD | 0.00% | -1.16% | +8.35% | -15.82% | 2.24 B USD | ||
| 223 | CLDX Celldex Therapeutics, Inc | 33.8700 USD | +1.62% | +4.38% | +13.28% | +24.34% | 2.25 B USD | ||
| 224 | DAWN Day One Biopharmaceuticals, Inc. Common Stock | 21.47 USD | +0.05% | +0.05% | +0.70% | +205.84% | 2.22 B USD | ||
| 225 | PAHC Phibro Animal Health Corporation Class A | 55.01 USD | -6.79% | -5.63% | +9.63% | +229.60% | 2.23 B USD | ||
| 226 | DFTX Definium Therapeutics, Inc. Common Shares | 22.15 USD | +1.00% | +5.38% | +21.04% | +46.59% | 2.21 B USD | ||
| 227 | SNDX Syndax Pharmaceuticals, Inc. | 24.37 USD | -0.25% | -0.77% | +3.00% | +117.01% | 2.15 B USD | ||
| 228 | BHC Bausch Health Companies Inc | 5.75 USD | +1.05% | +8.29% | +15.00% | +27.21% | 2.13 B USD | ||
| 229 | AUPH Aurinia Pharmaceuticals Inc | 16.0500 USD | -0.12% | +1.01% | +13.99% | +34.53% | 2.13 B USD | ||
| 230 | STOK Stoke Therapeutics, Inc. Common Stock | 35.54 USD | -0.89% | +2.63% | +5.90% | +365.79% | 2.10 B USD | ||
| 231 | NEOG Neogen Corp | 9.42 USD | -1.98% | +2.39% | +1.62% | +93.43% | 2.05 B USD | ||
| 232 | GRAL GRAIL, Inc. Common Stock | 49.7900 USD | -1.39% | -2.20% | +10.01% | -49.71% | 2.04 B USD | ||
| 233 | SION Sionna Therapeutics, Inc. Common Stock | 45.0900 USD | +4.13% | +22.69% | +19.76% | +14.62% | 2.03 B USD | ||
| 234 | SEM SELECT MEDICAL HOLDINGS CORP | 16.3800 USD | -0.12% | +0.12% | +0.74% | +15.03% | 2.03 B USD | ||
| 235 | ZYME Zymeworks Inc. | 27.7300 USD | +2.78% | +5.56% | +19.68% | +56.31% | 2.05 B USD | ||
| 236 | CAPR Capricor Therapeutics Inc | 35.04 USD | +0.92% | +12.24% | +14.81% | +262.73% | 2.02 B USD | ||
| 237 | MESO Mesoblast Limited American Depositary Shares | 15.75 USD | +7.80% | +11.15% | +8.10% | +49.71% | 2.02 B USD | ||
| 238 | RNA Atrium Therapeutics, Inc. Common Stock | 14.5550 USD | +3.82% | +6.24% | +5.62% | -79.30% | 2.00 B USD | ||
| 239 | WGS GeneDx Holdings Corp. Class A Common Stock | 67.96 USD | +1.66% | +3.61% | -12.69% | -30.99% | 1.99 B USD | ||
| 240 | ANAB AnaptysBio, Inc. Common Stock | 68.0050 USD | -3.15% | +3.76% | +4.78% | +93.20% | 1.96 B USD |
Notizie Titoli del Settore Sanitario
CareDx vende la divisione prodotti da laboratorio per 170 milioni di dollari in contanti
Le azioni QuidelOrtho crollano per le deboli previsioni sui ricavi
US-Iran Peace Hopes Push the S&P 500 and Nasdaq 100 to Record Highs
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%
Il titolo Avanos Medical raggiunge il massimo a 52 settimane a 24,72 USD
FDA estende la revisione della domanda di molgramostim di Savara
Glaukos riceve nuovo codice J per il trattamento della cheratocono Epioxa
Gainers Titoli del Settore Sanitario
IMMP Immutep Limited American Depositary Shares | 0.54 | +74.19% |
CUE Cue Biopharma, Inc. | 0.72 | +63.64% |
NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
NOTV Inotiv, Inc. Common Stock | 0.35 | +40.00% |
NXGL NexGel, Inc Common Stock | 0.76 | +28.81% |
PDSB PDS Biotechnology Corporation Common Stock | 1.36 | +28.30% |
TSHA Taysha Gene Therapies, Inc. Common Stock | 5.97 | +26.75% |
Losers Titoli del Settore Sanitario
WORX SC WORX Corp | 1.06 | -30.72% |
CMND Clearmind Medicine Inc. Common Shares | 0.65 | -28.57% |
BEAT Heartbeam, Inc. Common Stock | 0.89 | -25.83% |
TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0796 | -20.32% |
JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
TOIIW The Oncology Institute, Inc. Common Stock | 0.0399 | -18.40% |
ONCO Onconetix, Inc. Common Stock | 0.7601 | -16.47% |